93 related articles for article (PubMed ID: 79543)
1. Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells.
Hanna N; Ovadia H; Nelken D
Immunology; 1978 Jun; 34(6):1007-15. PubMed ID: 79543
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of normal immunosuppressive protein on lymphocytes mediating natural killing activity.
Goren R; Nelken D
Immunology; 1981 Mar; 42(3):427-30. PubMed ID: 6162784
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of T- and B-lymphocyte functions by normal immunosuppressive protein.
Hanna N; Kalderon R; Nelken D
Immunology; 1975 Sep; 29(3):433-43. PubMed ID: 51828
[TBL] [Abstract][Full Text] [Related]
4. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
Gordon WC; Prager MD
Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
[TBL] [Abstract][Full Text] [Related]
5. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
6. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
7. Normal immunosuppressive protein: in vitro inhibition of DNA synthesis in T and B lymphocytes and lymphoid cell lines.
Ovadia H; Hanna N; Beiss B; Nelken D
Isr J Med Sci; 1979 Oct; 15(10):847-53. PubMed ID: 93092
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
[TBL] [Abstract][Full Text] [Related]
9. In vitro sensitization of human lymphocytes against allogeneic cells by antigen-fed macrophages.
Treves AJ; Heidelberger E; Feldman M; Kaplan HS
Isr J Med Sci; 1979 Jul; 15(7):564-9. PubMed ID: 478818
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
[TBL] [Abstract][Full Text] [Related]
11. Non-specific normal immunosuppressive protein (Nip): purification and further biochemical characterization.
Gavison-Goren R; Nelken D
Immunology; 1983 Aug; 49(4):599-608. PubMed ID: 6192080
[TBL] [Abstract][Full Text] [Related]
12. The blocking effect of conditioned media from tumour cell cultures on the lysis of target cells by immune lymphocytes and macrophages.
Lavrovsky VA; Tikhonov VJ; Rubzov NB; Razvorotnev VA
Folia Biol (Praha); 1976; 22(2):101-7. PubMed ID: 1278566
[TBL] [Abstract][Full Text] [Related]
13. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
Rees RC; Reynolds CW; Herberman RB
Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862
[TBL] [Abstract][Full Text] [Related]
14. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.
Clark DA; Chaput A; Walker C; Rosenthal KL
J Immunol; 1985 Mar; 134(3):1659-64. PubMed ID: 3871455
[TBL] [Abstract][Full Text] [Related]
15. Generation of suppressor lymphocytes during sensitization in culture against a syngeneic tumor: affinity chromatography on insolubilized histamine.
Schechter B; Segal S; Feldman M
J Immunol; 1978 Apr; 120(4):1268-73. PubMed ID: 641348
[TBL] [Abstract][Full Text] [Related]
16. Cell surface receptors involved in the attachment of murine cytotoxic T lymphocytes to target cells - a study with xenoantisera to T-cell antigens.
Rabinowitz R; Levy J; Schlesinger M
Thymus; 1983 Apr; 5(3-4):127-39. PubMed ID: 6603681
[TBL] [Abstract][Full Text] [Related]
17. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
Williams RM; Germain RN; Benacerraf B
J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the cytotoxic response of mouse lymphocytes to syngeneic tumor cells by tumor-promoting phorbol ester.
Fredrickson GG; Bennett M
Cancer Res; 1982 Sep; 42(9):3601-6. PubMed ID: 7105034
[TBL] [Abstract][Full Text] [Related]
20. Natural cytotoxic cells against solid tumors in mice: a comparison with natural killer cells.
Stutman O; Lattime EC; Figarella EF
Fed Proc; 1981 Oct; 40(12):2699-704. PubMed ID: 7286250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
